ISL
CVS icon

Ingalls & Snyder LLC’s CVS Health CVS Stock Holding History

Ingalls & Snyder LLC’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.11M Buy
15,525
+40
+0.3% +$3.08K 0.04% 205
2025
Q4 		$1.23M Sell
15,485
-200
-1% -$15.8K 0.05% 208
2025
Q3 		$1.18M Sell
15,685
-138
-0.9% -$9.46K 0.04% 216
2025
Q2 		$1.09M Sell
15,823
-875
-5% -$57.4K 0.04% 217
2025
Q1 		$1.13M Sell
16,698
-1,078
-6% -$64.5K 0.04% 211
2024
Q4 		$798K Sell
17,776
-9,660
-35% -$542K 0.03% 236
2024
Q3 		$1.73M Buy
27,436
+173
+0.6% +$10.1K 0.07% 164
2024
Q2 		$1.61M Sell
27,263
-27,651
-50% -$1.73M 0.07% 167
2024
Q1 		$4.38M Sell
54,914
-3,108
-5% -$237K 0.19% 86
2023
Q4 		$4.58M Sell
58,022
-5,712
-9% -$407K 0.21% 80
2023
Q3 		$4.45M Sell
63,734
-205
-0.3% -$14.5K 0.21% 81
2023
Q2 		$4.42M Buy
63,939
+1,902
+3% +$135K 0.21% 80
2023
Q1 		$4.61M Sell
62,037
-1,177
-2% -$98.7K 0.24% 72
2022
Q4 		$5.89M Sell
63,214
-325
-0.5% -$31.4K 0.32% 58
2022
Q3 		$6.06M Sell
63,539
-775
-1% -$76.7K 0.34% 54
2022
Q2 		$5.96M Sell
64,314
-315
-0.5% -$30.7K 0.31% 61
2022
Q1 		$6.54M Buy
64,629
+345
+0.5% +$36.2K 0.29% 67
2021
Q4 		$6.63M Buy
64,284
+353
+0.6% +$32.6K 0.3% 66
2021
Q3 		$5.42M Buy
63,931
+1,077
+2% +$90.2K 0.25% 79
2021
Q2 		$5.25M Sell
62,854
-5,259
-8% -$431K 0.23% 85
2021
Q1 		$5.12M Buy
68,113
+11,675
+21% +$850K 0.24% 78
2020
Q4 		$3.85M Buy
56,438
+973
+2% +$63.3K 0.19% 96
2020
Q3 		$3.24M Buy
55,465
+7,281
+15% +$453K 0.22% 86
2020
Q2 		$3.13M Buy
48,184
+1,216
+3% +$76.6K 0.18% 101
2020
Q1 		$2.79M Sell
46,968
-519
-1% -$34.6K 0.19% 102
2019
Q4 		$3.53M Sell
47,487
-262
-0.5% -$18.4K 0.19% 100
2019
Q3 		$3.01M Sell
47,749
-769
-2% -$45.6K 0.15% 117
2019
Q2 		$2.64M Buy
48,518
+27,634
+132% +$1.49M 0.13% 132
2019
Q1 		$1.13M Buy
20,884
+1,314
+7% +$81.1K 0.05% 205
2018
Q4 		$1.28M Buy
19,570
+12,073
+161% +$901K 0.07% 185
2018
Q3 		$590K Sell
7,497
-310
-4% -$22.2K 0.02% 288
2018
Q2 		$502K Sell
7,807
-1,008
-11% -$66.4K 0.02% 275
2018
Q1 		$548K Buy
8,815
+520
+6% +$37.3K 0.03% 259
2017
Q4 		$601K Sell
8,295
-11,380
-58% -$827K 0.03% 259
2017
Q3 		$1.6M Buy
19,675
+1,419
+8% +$112K 0.08% 157
2017
Q2 		$1.47M Buy
18,256
+2,609
+17% +$206K 0.08% 161
2017
Q1 		$1.23M Buy
15,647
+3,225
+26% +$257K 0.07% 180
2016
Q4 		$980K Buy
12,422
+6,897
+125% +$558K 0.05% 197
2016
Q3 		$492K Buy
5,525
+95
+2% +$8.97K 0.03% 252
2016
Q2 		$520K Buy
5,430
+1,525
+39% +$152K 0.03% 249
2016
Q1 		$405K Buy
3,905
+60
+2% +$5.83K 0.03% 245
2015
Q4 		$375K Buy
3,845
+330
+9% +$32.3K 0.02% 260
2015
Q3 		$339K Buy
3,515
+229
+7% +$24.1K 0.02% 262
2015
Q2 		$344K Buy
3,286
+725
+28% +$74.1K 0.02% 274
2015
Q1 		$264K Sell
2,561
-251
-9% -$25.4K 0.01% 309
2014
Q4 		$270K Sell
2,812
-200
-7% -$17.6K 0.02% 310
2014
Q3 		$239K Buy
3,012
+100
+3% +$7.88K 0.01% 327
2014
Q2 		$219K Sell
2,912
-112
-4% -$8.46K 0.01% 346
2014
Q1 		$226K Sell
3,024
-200
-6% -$14.1K 0.01% 331
2013
Q4 		$230K Buy
+3,224
New +$207K 0.01% 308

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ingalls & Snyder LLC's CVS Position: Q1 2026 in Review

Ingalls & Snyder LLC increased its CVS Health (CVS) stake by 0.26% in Q1 2026, buying an estimated $3.08K and bringing the position to 15,525 shares worth $1.11M. The position accounts for 0.04% of the portfolio, ranked #205.

Ingalls & Snyder LLC first reported a position in CVS in Q4 2013 and has held it in 50 quarters since. The position peaked at $6.63M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Ingalls & Snyder LLC held 15,525 shares of CVS Health worth $1.11M as of Q1 2026.
  • Ingalls & Snyder LLC bought 40 CVS Health shares in Q1 2026, an estimated $3.08K.
  • CVS Health made up 0.04% of Ingalls & Snyder LLC's portfolio in Q1 2026, its #205 holding.
  • Ingalls & Snyder LLC first reported a position in CVS Health in Q4 2013 and has held it in 50 quarters since.
  • Ingalls & Snyder LLC's CVS Health position peaked at $6.63M in Q4 2021.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2026, filed 13 May 2026.